Tasmea (TEA.AX) Earnings Analysis
Tasmea (TEA.AX) next reports earnings on 2026-08-31, consensus EPS 0.1717 AUD. Last quarter (2026-02-23) it missed with EPS 0.105 AUD vs 0.131 AUD est (-19.8%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E 47.23.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TEA.AX next report earnings?
| Next earnings date | 2026-08-31 |
|---|---|
| Consensus EPS estimate | 0.1717 AUD |
| Revenue estimate | 0.89B |
TEA.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-23 | 0.105 AUD | 0.131 AUD | -19.8% | Miss |
| 2025-06-30 | 0.1065 AUD | 0.115 AUD | -7.4% | Miss |
| 2025-02-24 | 0.1232 AUD | 0.152 AUD | -18.9% | Miss |
| 2024-08-26 | 0.06621 AUD | n/a | n/a | n/a |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
TEA.AX valuation and analyst view
| Trailing P/E | 47.23 |
|---|---|
| Trailing EPS | 0.18942 AUD |
| Price / book | 8.88 |
| Dividend yield | 2.34% |
| Market cap | 2.56B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Tasmea (TEA.AX)'s next earnings date?
Tasmea is next scheduled to report on 2026-08-31, with a consensus EPS estimate of 0.1717 AUD and revenue estimate of 0.89B.
Did TEA.AX beat earnings last quarter?
In its 2026-02-23 report, TEA.AX posted EPS of 0.105 AUD versus a 0.131 AUD estimate — a miss of 19.8%.
What is TEA.AX's earnings track record?
Over the last 3 reported quarters with consensus data, TEA.AX beat estimates 0 times (0%).
What is TEA.AX's current P/E ratio and EPS?
TEA.AX trades at a trailing P/E of 47.23 on trailing EPS of 0.18941848318564572 AUD.
What do analysts rate TEA.AX?
TEA.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.